Among 190 pancreatic cancer patients, the positive yield was 10.5% (n = 20), and positive results were most commonly identified in ATM (40.0%; 8/20), BRCA2 (25.0%; 5/20), and PALB2 (15.0%; 3/20). This evidence concerns the gene BRCA2 and pancreatic neoplasm.